+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
WELCURE WELCURE

Welcure Drugs & Pharmaceuticals Share Price

 
New 52W Low in past week

03 Nov, 2026 1:32 PM (IST)

Welcure Drugs & Pharmaceuticals live price: ₹0.19.

Welcure Drugs & Pharmaceuticals Performance

  • Today's Low
  • ₹0
  • Today's High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹1
  • Open Price₹0
  • Previous Close₹0
  • Volume1,115,679
  • 50 DMA₹0.20
  • 100 DMA₹0.20
  • 200 DMA₹0.30

Welcure Drugs & Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -9.52%
  • Over 3 Month -20.83%
  • Over 6 Month -32.14%
  • Over 1 Year -65.45%

Smart Investing Starts Here Start SIP with Welcure Drugs & Pharmaceuticals for Steady Growth!

Invest Now

Welcure Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1.4
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 24
  • P/B Ratio
  • 0.2
  • Average True Range
  • 0
  • EPS
  • -0.1
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 44.09
  • MFI
  • 22.92

Latest Stock News Updates

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On October 31, 2026

Approval of the Audited Standalone Financial Results and Audited Standalone Financial Statements

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd Held On Today I.E. Tuesday, 14Th July, 2026.

Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd held on today i.e. Tuesday, 14th July, 2026.

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

Resignation of Company Secretary and Compliance Officer

Welcure Drugs & Pharmaceuticals Financials

Welcure Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹0.19
0 (0%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹0.20
  • 50 Day
  • ₹0.20
  • 100 Day
  • ₹0.20
  • 200 Day
  • ₹0.30

Resistance and Support

0.2 Pivot Speed
  • R3 0.20
  • R2 0.20
  • R1 0.20
  • S1 0.20
  • S2 0.20
  • S3 0.20

Welcure Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results
2026-02-12 Quarterly Results
2025-12-05 Right Issue of Equity Shares
2025-11-27 To consider raisinf of funds Inter-alia, 1. To augment the financial resources of the Company via funds raising by way of issue of equity shares/convertible instruments/other securities through permissable modes.
2025-11-13 Quarterly Results
Date Purpose Remarks
2025-10-16 Split Stock split from Rs. 10/- to Re. 1/-.
Date Purpose Remarks
2025-10-16 Bonus Bonus issue of equity shares in the ratio of 1:10 of Re. 1/-.

Welcure Drugs & Pharmaceuticals Shareholding Pattern

100%
0%
0%

About Welcure Drugs & Pharmaceuticals

Welcure Drugs & Pharmaceuticals manufactures and trades pharmaceutical drugs. The Company manufactures a wide range of drugs in formulations that include tablets, capsules, liquid orals, and dry syrups. View More
  • NSE Symbol
  • WELCURE
  • BSE Symbol
  • 524661
  • ISIN
  • INE331C01025

Similar Stocks to Welcure Drugs & Pharmaceuticals

Welcure Drugs & Pharmaceuticals FAQs

Welcure Drugs & Pharmaceuticals share price is ₹0 As on 03 November, 2026 | 13:23

The Market Cap of Welcure Drugs & Pharmaceuticals is ₹23.5 Cr As on 03 November, 2026 | 13:23

The P/E ratio of Welcure Drugs & Pharmaceuticals is -1.4 As on 03 November, 2026 | 13:23

The PB ratio of Welcure Drugs & Pharmaceuticals is 0.2 As on 03 November, 2026 | 13:23

The 52 week High & Low of Welcure Drugs & Pharmaceuticals is ₹0.6/₹0.2 respectively As on 03 November, 2026 | 13:23

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23